MEDICAMEN BIOTECH
|
The Current P/E Ratio of MEDICAMEN BIOTECH is 71.72.
| Share Price | ₹384.6 | Nov 04,2025 |
| Market Cap | ₹523.1 Cr | |
| Earnings-TTM | ₹7.3 Cr | TTM-Consolidated Results |
| Price/Earnings | 71.72x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹523.1 Cr] as on Nov 04,2025
(/) Earnings [ ₹7.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 71.72x ]
Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 71.72 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH
PE Ratio Performance Analysis for MEDICAMEN BIOTECH
- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 61.52x.
- MEDICAMEN BIOTECH 's operated at median p/e ratio of 53.78x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2025 at 93.43x.
- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2024 of 51.31x.
How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| MEDICAMEN BIOTECH | 7.29 | 71.72 | 523.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 39.01 | 406,147.0 |
| DIVIS LABORATORIES LTD | 2,306.00 | 78.27 | 180,488.0 |
| CIPLA LTD | 5,453.86 | 22.27 | 121,452.0 |
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.47 | 121,057.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.52 | 100,220.0 |
| MANKIND PHARMA LTD | 1,905.51 | 51.32 | 97,796.9 |
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.11 | 97,891.5 |
| LUPIN LTD | 3,722.18 | 24.52 | 91,267.9 |
| AUROBINDO PHARMA LTD | 3,417.93 | 19.56 | 66,850.3 |
| ABBOTT INDIA LTD | 1,452.29 | 42.97 | 62,401.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.52x |
| Max industry PE | 78.27x |
| Median industry PE | 39.01x |
| Average industry PE | 40.79x |
You may also like the below Video Courses